Cancel anytime
Koninklijke Philips NV ADR (PHG)PHG
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: PHG (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: 9.75% | Upturn Advisory Performance 3 | Avg. Invested days: 41 |
Profits based on simulation | Stock Returns Performance 2 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: 9.75% | Avg. Invested days: 41 |
Upturn Star Rating | Stock Returns Performance 2 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 24.20B USD |
Price to earnings Ratio - | 1Y Target Price 34.5 |
Dividends yield (FY) - | Basic EPS (TTM) -0.51 |
Volume (30-day avg) 858307 | Beta 0.79 |
52 Weeks Range 18.85 - 32.91 | Updated Date 11/20/2024 |
Company Size Large-Cap Stock | Market Capitalization 24.20B USD | Price to earnings Ratio - | 1Y Target Price 34.5 |
Dividends yield (FY) - | Basic EPS (TTM) -0.51 | Volume (30-day avg) 858307 | Beta 0.79 |
52 Weeks Range 18.85 - 32.91 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-10-28 | When BeforeMarket |
Estimate 0.35 | Actual 0.32 |
Report Date 2024-10-28 | When BeforeMarket | Estimate 0.35 | Actual 0.32 |
Profitability
Profit Margin -1.82% | Operating Margin (TTM) 7.72% |
Management Effectiveness
Return on Assets (TTM) 1.36% | Return on Equity (TTM) -4.59% |
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 13.11 |
Enterprise Value 31094258219 | Price to Sales(TTM) 1.34 |
Enterprise Value to Revenue 1.63 | Enterprise Value to EBITDA 126.51 |
Shares Outstanding 931886016 | Shares Floating 768899779 |
Percent Insiders - | Percent Institutions 6.87 |
Trailing PE - | Forward PE 13.11 | Enterprise Value 31094258219 | Price to Sales(TTM) 1.34 |
Enterprise Value to Revenue 1.63 | Enterprise Value to EBITDA 126.51 | Shares Outstanding 931886016 | Shares Floating 768899779 |
Percent Insiders - | Percent Institutions 6.87 |
Analyst Ratings
Rating 4 | Target Price 17.44 | Buy 1 |
Strong Buy 1 | Hold 1 | Sell - |
Strong Sell - |
Rating 4 | Target Price 17.44 | Buy 1 | Strong Buy 1 |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
Koninklijke Philips NV ADR (PHG): A Comprehensive Overview
Company Profile:
Detailed history and background:
- Founded in 1891 in Eindhoven, Netherlands, Philips started as a lightbulb manufacturer and has grown into a global leader in health technology.
- The company transitioned from manufacturing electronics to focusing on medical equipment and healthcare in the late 20th century.
- In 2021, Philips completed the spin-off of its lighting division, now known as Signify (OTCQX: PHLKY).
Core business areas:
- Health Technology: Imaging, Diagnosis & Treatment, Patient Monitoring & Informatics, Connected Care, Personal Health.
- Home appliances: Air Treatment, Coffee, Food Preparation, Garment Care, Home Cleaning, Personal Care.
Leadership and corporate structure:
- CEO: Frans van Houten (since 2011)
- Chairman of the supervisory board: Feike Sijbesma
- Management Board includes Chief Financial Officer, Chief Business Leaders for each segment, Chief Medical Officer, Chief Innovation & Strategy Officer.
Top Products and Market Share:
Top Products:
- Healthcare: Diagnostic and therapeutic imaging systems (CT scanners, MRI, PET/CT), ultrasound machines, medical monitors, patient care solutions.
- Home Appliances: Air purifiers, coffee machines, shavers, garment steamers, vacuum cleaners.
Market Share:
- Global leader in healthcare technology: #1 in diagnostic imaging, #2 in image-guided therapy, #3 in patient monitoring.
- Strong market positions in home appliances: #1 in air purifiers, #2 in coffee machines, #3 in electric shavers.
Competitive Landscape:
- Healthcare: GE Healthcare (GE), Siemens Healthineers (SHLM), Medtronic (MDT)
- Home Appliances: Dyson (DCNHY), Whirlpool (WHR), Electrolux (ELUXB)
Total Addressable Market (TAM):
Healthcare: Global market expected to reach $634 billion by 2025. Home Appliances: Global market expected to reach $427 billion by 2025.
Financial Performance:
- Revenue: €19.5 billion in 2022 (5.2% YoY increase)
- Net Income: €1.5 billion in 2022
- Profit Margin: 7.7% in 2022
- EPS: €0.83 in 2022
- Cash Flow: €1.7 billion in 2022
- Balance Sheet: Strong liquidity and low debt-to-equity ratio.
Dividends and Shareholder Returns:
- Dividend History: Dividend payout ratio of 43% in 2022. Recent dividend per share: €0.88.
- Shareholder Returns: Total return of 23.4% in the past year (as of October 27, 2023).
Growth Trajectory:
- Historical growth: Revenue grew at a CAGR of 4.2% over the last 5 years.
- Future growth: Expected to grow at a CAGR of 5% in the next 5 years driven by healthcare innovation and expanding presence in emerging markets.
- Growth Initiatives: New product launches, strategic partnerships, expanding digital healthcare solutions.
Market Dynamics:
- Industry Trends: Increasing demand for healthcare services, aging population, technological advancements in medical imaging and home appliances.
- Positioning: Strong brand reputation, focus on innovation, commitment to sustainability.
Competitors:
Competitor | Stock Symbol | Market Share (Healthcare) |
---|---|---|
GE Healthcare | GE | 19% |
Siemens Healthineers | SHLM | 16% |
Medtronic | MDT | 15% |
Philips | PHG | 13% |
Challenges and Opportunities:
Challenges:
- Supply chain disruptions
- Regulatory hurdles
- Intense competition
Opportunities:
- Expanding in emerging markets
- Developing new healthcare technologies
- Growing digital healthcare business
Recent Acquisitions (last 3 years):
- 2021: BioTelemetry Inc. ($2.8 billion): Expands PHG's cardiac monitoring and diagnostics capabilities.
- 2022: Capsule Technologies Inc. ($625 million): Strengthens PHG's position in telehealth and remote patient monitoring.
AI-Based Fundamental Rating:
Rating: 7/10
Justification: Strong financial health, favorable market position, and promising growth prospects offset by recent challenges like supply chain disruptions.
Sources:
- https://www.philips.com/a-w/about/company/company-information
- https://www.philips.com/a-w/about/annual-reports.html
- https://finance.yahoo.com/quote/PHG/
- https://www.statista.com/statistics/266038/worldwide-revenue-of-medical-imaging-equipment-market/
- https://www.statista.com/outlook/dmo/household/household-appliances/worldwide
Disclaimer:
This information is provided for educational purposes only and should not be considered financial advice. Please consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Koninklijke Philips NV ADR
Exchange | NYSE | Headquaters | - |
IPO Launch date | 1987-12-30 | President, CEO & Chairman of the Board of Management | Mr. Roy Jakobs |
Sector | Healthcare | Website | https://www.philips.com |
Industry | Medical Devices | Full time employees | 69282 |
Headquaters | - | ||
President, CEO & Chairman of the Board of Management | Mr. Roy Jakobs | ||
Website | https://www.philips.com | ||
Website | https://www.philips.com | ||
Full time employees | 69282 |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.